| Application no. and date | 21728101.3 (espacenet) (Federated) (European Patent Register), 20210518 | | Patent/reg. no. and date | DK/EP 3962455, 20220831 | | Publication date | 20220309 | | Priority no. and date | GB 202007306, 20200518, GB 202009905, 20200629, GB 202018901, 20201201 | | EP pub. no. and date |
EP 3962455 20220309 | | Effective date | | | Applicant/owner | Orexo AB, Box 303
751 05 Uppsala, SE | | Applicant ref. no. | OREQ/P77028EP | | Inventor | Fischer, Andreas,
751 05 Uppsala, SE,
SÄVMARKER, Jonas,
751 05 Uppsala, SE,
RÖNN, Robert,
751 05 Uppsala, SE | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 38/00 (2006.01) , A61K 38/095 (2019.01) , A61K 9/00 (2006.01) , A61K 9/16 (2006.01) , A61P 13/00 (2006.01) | | Title | NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY | | Int. application no. | GB2021051191 | | Int. publication no. | WO2021234366 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
